High-throughput tracking enables systematic phenotyping and drug repurposing in C. elegans disease models
There are thousands of Mendelian diseases with more being discovered weekly and the majority have no approved treatments. To address this need, we require scalable approaches that are relatively inexpensive compared to traditional drug development. In the absence of a validated drug target, phenotyp...
Saved in:
Main Authors: | Thomas J O'Brien, Ida L Barlow, Luigi Feriani, André EX Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2025-01-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/92491 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IUPHAR review: Drug repurposing in Schizophrenia – An updated review of clinical trials
by: Jihan K. Zaki, et al.
Published: (2025-03-01) -
Comprehensive evaluation of pure and hybrid collaborative filtering in drug repurposing
by: Clémence Réda, et al.
Published: (2025-01-01) -
Drug repurposing screen for the rare disease ataxia-telangiectasia
by: Namrata Jayanth, et al.
Published: (2025-01-01) -
HEDDI-Net: heterogeneous network embedding for drug-disease association prediction and drug repurposing, with application to Alzheimer’s disease
by: Yin-Yuan Su, et al.
Published: (2025-02-01) -
Integrative transcriptome profiling for identifying ALS potential treatment using the drug repurposing approach
by: Navid Kashani, et al.
Published: (2025-01-01)